Cover Image
Market Research Report

Automated Compounding Devices (Oncology) (ACD) -Market Insights, Competitive Landscape and Market Forecast-2025

Published by DelveInsight Business Research LLP Product code 971242
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Automated Compounding Devices (Oncology) (ACD) -Market Insights, Competitive Landscape and Market Forecast-2025
Published: November 18, 2020 Content info: 120 Pages
Description

DelveInsight's 'Automated Compounding Devices (Oncology) (ACD) -Market Insights, Competitive Landscape and Market Forecast-2025' report delivers an in-depth understanding of Automated Compounding Devices (Oncology) and the historical and forecasted Automated Compounding Devices (Oncology) market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Automated Compounding Devices (Oncology) market report provides an overview of Automated Compounding Devices (Oncology), reasons to get ACD (Oncology) as well as its advantages and limitations. Additionally, the report provides insight on the ACD (Oncology) market share of the individual ACD devices, current and forecasted ACD (Oncology) market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Automated Compounding Devices (Oncology) Overview

The automated compound devices (ACD) helps in combining several drug solutions to a common container for final administration of the drug within the patient. It helps to eliminate the manual errors and involves the use of computerized algorithms in preparation of the cytotoxic drugs, considering risks associated with the handling of carcinogens for prolonged periods of time, and the extremely personalized treatment in case of cancer patients further increases the chances of an error.

The technology used in ACD comprises of two main methods namely, the gravimetric method and the volumetric methods. Additionally, chemotherapeutic drugs involved are sometimes highly toxic, with a low therapeutic index making it a necessity to prepare the drugs with high precision. The accuracy of these ACD is dependent proportionally on the volume that has to be transferred indicating the higher the volume, more will be the accuracy of the device. Therefore, manufacturers offer a range of volumes that can be transferred, fulfilling the needs of an entire range of customers. The devices are deployed in both hospital settings and pharmacies, measuring powders and liquid component both.

Study Period: 2017-2025

Geography Covered:

  • The US
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

List of companies

  • Comecer
  • Arxium
  • Loccioni
  • ICU Medical
  • Omnicell, Inc
  • Baxter Healthcare Corporation
  • Grifols International
  • S.A., Equashield
  • B. Braun Medical Inc.

More companies in the report…

Automated Compounding Devices (Oncology)- Competitive Analysis

This segment of the report provides a brief competitive analysis of Automated Compounding Devices, to help understand the competition in the market. It gives a comparative understanding of the products based on product type.

Automated Compounding Devices (Oncology): Market Analysis

This segment illustrates the market of Automated Compounding Devices (Oncology) across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.

Automated Compounding Devices (Oncology): Market Segmentation

By Type

  • Macro Automated Compounding Systems
  • Micro Automated Compounding Systems
  • Macro/Micro Automated Compounding Systems

By Technology

  • Gravimetric Automated Compounding Systems
  • Volumetric Automated Compounding Systems

By End-User

  • Hospitals
  • Chemotherapy Centers
  • Pharmacies

Automated Compounding Devices (Oncology): Market Drivers and Barriers

The report provides insights into the market driving factors and the barriers shaping the Automated Compounding Devices (Oncology) Market.

The growth of ACD market is driven by an increasing need to reduce the medicinal errors, increasing interest of cancer patients in the field of personalized medicines and chemotherapy. The cost incurred at the hospitals per dose is reduced and elimination of contamination while compounding solutions are some major advantages that can help in shaping the ACD market.

However, higher buying and installation cost for the ACD devices are strict regulations pertaining to the ACD are some of the barriers that can obstruct the propelling growth of the ACD market.

Industry Trends

There have been various developments and collaborations in the field of Automated Compounding Devices products. In the late 2018, Arxium launched its cGMP RIVA IV compounding system for hospital and pharmacy use. Fagron acquired JCB Laboratories to reshape the U.S. Sterile Compounding Industry and later in the year 2019, it has announced of opening one of the largest 503B human drug outsourcing facilities in the U.S. in November utilizing automation. In January 2020, Omnicell, Inc. announced that Allegheny General Hospital, Pittsburgh, Pa., part of Allegheny Health Network (AHN), has selected Omnicell's Central Pharmacy IV Compounding Service, a comprehensive, turnkey approach for insourcing some sterile compounding operations.

KOL- Views

To keep up with the market trends, we take KOLs and SME's opinion working in Automated Compounding Devices (Oncology) domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Automated Compounding Devices (Oncology) market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report:

  • The report covers the descriptive overview of Automated Compounding Devices (Oncology), explaining the reasons for replacement, procedure, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Automated Compounding Devices (Oncology) is provided, which will have an impact on the future market of Automated Compounding Devices (Oncology).
  • A detailed review of Automated Compounding Devices (Oncology) market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Automated Compounding Devices (Oncology) market.

Report Highlights:

  • The report covers descriptive overview of the Automated Compounding Devices (Oncology), explaining its applications, working mechanism, etc.
  • The report provides an insight into the patient population eligible for Implantation of Cardiac monitors in the 7 MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
  • The report is a comprehensive account of marketed devices present in the Automated Compounding Devices (Oncology) market.
  • The report also reviews the detailed global historical and forecasted Automated Compounding Devices (Oncology) devices market including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the global Automated Compounding Devices (Oncology) market.

Automated Compounding Devices (Oncology) Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • Market Size

Automated Compounding Devices (Oncology) Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL'S views

Key Questions:

Market Insights:

  • What was the Automated Compounding Devices (Oncology) market share (%) distribution in 2017 and how it will look like in 2025?
  • What will be the Automated Compounding Devices (Oncology) total market Size as well as market Size by devices across the 7MM during the forecast period (2017-2025)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Automated Compounding Devices (Oncology) market Size during the forecast period (2017-2025)?
  • At what CAGR, the Automated Compounding Devices (Oncology) market is expected to grow in 7MM during the forecast period (2017-2025)?
  • What will be the Automated Compounding Devices (Oncology) market outlook across the 7MM during the forecast period (2017-2025)?
  • What will be the Automated Compounding Devices (Oncology) market growth till 2025 and what will be the resultant market Size in the year 2025?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?

Competitive Landscape:

  • What are the current devices available in the Automated Compounding Devices (Oncology) market?
  • What is the Automated Compounding Devices (Oncology) available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Automated Compounding Devices (Oncology)?
  • What are the key collaborations (Industry-Industry), Mergers and acquisitions, licensing activities related to the Automated Compounding Devices (Oncology)?
  • What are the key designations that have been granted for the current Automated Compounding Devices (Oncology)?
  • What are the global historical and forecasted market of Automated Compounding Devices (Oncology)?
Table of Contents
Product Code: DIMDCL0002

Table of Contents

1. Key Insights

2. Executive Summary of Automated Compounding Devices (Oncology)

3. Automated Compounding Devices (Oncology): Background and Overview

  • 3.1. Introduction

4. Marketed Products

  • 4.1. PHARMODUCT Automated Compounding System: Comecer
    • 4.1.1. Product Description
    • 4.1.2. Regulatory Milestones
    • 4.1.3. Research and Development
    • 4.1.4. Product Development Activities
  • 4.2. RIVA: Arxium
    • 4.2.1. Product Description
    • 4.2.2. Regulatory Milestones
    • 4.2.3. Research and Development
    • 4.2.4. Product Development Activities
  • 4.3. APOTECAchemo: Loccioni
    • 4.3.1. Product Description
    • 4.3.2. Regulatory Milestones
    • 4.3.3. Research and Development
    • 4.3.4. Product Development Activities
  • 4.4. Diana Automated Sterile Compounding System: ICU Medical
    • 4.4.1. Product Description
    • 4.4.2. Regulatory Milestones
    • 4.4.3. Research and Development
    • 4.4.4. Product Development Activities
  • 4.5 ChemoClave: ICU Medical
    • 4.5.1 Product Description
    • 4.4.2. Regulatory Milestones
    • 4.4.3. Research and Development
    • 4.4.4. Product Development Activities

Products detail in the report…

5. Automated Compounding Devices: Competitive Analysis

6. ACD (Oncology): Market Analysis

  • 6.1. Automated Compounding Devices: Market Analysis in the 7MM (2017-2025)

6.1.1. Automated Compounding Devices: Market Analysis in the 7MM by type (2017-2025)

6.1.2. Automated Compounding Devices: Market Analysis in the 7MM by application (2017-2025)

6.1.3. Automated Compounding Devices: Market Analysis in the 7MM by end user (2017-2025)

  • 6.2. Automated Compounding Devices: United States Market Analysis (2017-2025)

6.1.1. Automated Compounding Devices: Market Analysis in the US by type (2017-2025)

6.1.2. Automated Compounding Devices: Market Analysis in the US by application (2017-2025)

6.1.3. Automated Compounding Devices: Market Analysis in the US by end user (2017-2025)

  • 6.3. Automated Compounding Devices: Germany Market Analysis (2017-2025)

6.1.1. Automated Compounding Devices: Market Analysis in Germany by type (2017-2025)

6.1.2. Automated Compounding Devices: Market Analysis in Germany by application (2017-2025)

6.1.3. Automated Compounding Devices: Market Analysis in Germany by end user (2017-2025)

  • 6.4. Automated Compounding Devices: France Market Analysis (2017-2025)

6.1.1. Automated Compounding Devices: Market Analysis in France by type (2017-2025)

6.1.2. Automated Compounding Devices: Market Analysis in France by application (2017-2025)

6.1.3. Automated Compounding Devices: Market Analysis in France by end user (2017-2025)

  • 6.5. Automated Compounding Devices: Italy Market Analysis (2017-2025)

6.1.1. Automated Compounding Devices: Market Analysis in Italy by type (2017-2025)

6.1.2. Automated Compounding Devices: Market Analysis in Italy by application (2017-2025)

6.1.3. Automated Compounding Devices: Market Analysis in Italy by end user (2017-2025)

  • 6.6. Automated Compounding Devices: Spain Market Analysis (2017-2025)

6.1.1. Automated Compounding Devices: Market Analysis in Spain by type (2017-2025)

6.1.2. Automated Compounding Devices: Market Analysis in Spain by application (2017-2025)

6.1.3. Automated Compounding Devices: Market Analysis in Spain by end user (2017-2025)

  • 6.7. Automated Compounding Devices: United Kingdom Market Analysis (2017-2025)

6.1.1. Automated Compounding Devices: Market Analysis in the UK by type (2017-2025)

6.1.2. Automated Compounding Devices: Market Analysis in the UK by application (2017-2025)

6.1.3. Automated Compounding Devices: Market Analysis in the UK by end user (2017-2025)

  • 6.8. Automated Compounding Devices: Japan Market Analysis (2017-2025)

6.1.1. Automated Compounding Devices: Market Analysis in Japan by type (2017-2025)

6.1.2. Automated Compounding Devices: Market Analysis in Japan by application (2017-2025)

6.1.3. Automated Compounding Devices: Market Analysis in Japan by end user (2017-2025)

7. Market Drivers

8. Market Barriers

9. Industry Trends

10. KOL's Views

11. Analyst Views

12. PEST Analysis

13. Appendix

  • 13.1. Bibliography
  • 13.2. Report Methodology

14. DelveInsight Capabilities

15. Disclaimer

16. About DelveInsight

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Automated Compounding Devices: Market Analysis in the 7MM (2017-2025)
  • Table 3: Automated Compounding Devices: Market Analysis in the 7MM by type (2017-2025)
  • Table 4: Automated Compounding Devices: Market Analysis in the 7MM by application (2017-2025)
  • Table 5: Automated Compounding Devices: Market Analysis in the 7MM by end user (2017-2025)
  • Table 6: Automated Compounding Devices: United States Market Analysis (2017-2025)
  • Table 7: Automated Compounding Devices: Market Analysis in the US by type (2017-2025)
  • Table 8: Automated Compounding Devices: Market Analysis in the US by application (2017-2025)
  • Table 9: Automated Compounding Devices: Market Analysis in the US by end user (2017-2025)
  • Table 10: Automated Compounding Devices: Germany Market Analysis (2017-2025)
  • Table 11: Automated Compounding Devices: Market Analysis in Germany by type (2017-2025)
  • Table 12: Automated Compounding Devices: Market Analysis in Germany by application (2017-2025)
  • Table 13: Automated Compounding Devices: Market Analysis in Germany by end user (2017-2025)
  • Table 14: Automated Compounding Devices: France Market Analysis (2017-2025)
  • Table 15: Automated Compounding Devices: Market Analysis in France by type (2017-2025)
  • Table 16: Automated Compounding Devices: Market Analysis in France by application (2017-2025)
  • Table 17: Automated Compounding Devices: Market Analysis in France by end user (2017-2025)
  • Table 18: Automated Compounding Devices: Italy Market Analysis (2017-2025)
  • Table 19: Automated Compounding Devices: Market Analysis in Italy by type (2017-2025)
  • Table 20: Automated Compounding Devices: Market Analysis in Italy by application (2017-2025)
  • Table 21: Automated Compounding Devices: Market Analysis in Italy by end user (2017-2025)
  • Table 22: Automated Compounding Devices: Spain Market Analysis (2017-2025)
  • Table 23: Automated Compounding Devices: Market Analysis in Spain by type (2017-2025)
  • Table 24: Automated Compounding Devices: Market Analysis in Spain by application (2017-2025)
  • Table 25: Automated Compounding Devices: Market Analysis in Spain by end user (2017-2025)
  • Table 26: Automated Compounding Devices: United Kingdom Market Analysis (2017-2025)
  • Table 27: Automated Compounding Devices: Market Analysis in the UK by type (2017-2025)
  • Table 28: Automated Compounding Devices: Market Analysis in the UK by application (2017-2025)
  • Table 29: Automated Compounding Devices: Market Analysis in the UK by end user (2017-2025)
  • Table 30: Automated Compounding Devices: Japan Market Analysis (2017-2025)
  • Table 31: Automated Compounding Devices: Market Analysis in Japan by type (2017-2025)
  • Table 32: Automated Compounding Devices: Market Analysis in Japan by application (2017-2025)
  • Table 33: Automated Compounding Devices: Market Analysis in Japan by end user (2017-2025)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Automated Compounding Devices: Market Analysis in the 7MM (2017-2025)
  • Figure 3: Automated Compounding Devices: Market Analysis in the 7MM by type (2017-2025)
  • Figure 4: Automated Compounding Devices: Market Analysis in the 7MM by application (2017-2025)
  • Figure 5: Automated Compounding Devices: Market Analysis in the 7MM by end user (2017-2025)
  • Figure 6: Automated Compounding Devices: United States Market Analysis (2017-2025)
  • Figure 7: Automated Compounding Devices: Market Analysis in the US by type (2017-2025)
  • Figure 8: Automated Compounding Devices: Market Analysis in the US by application (2017-2025)
  • Figure 9: Automated Compounding Devices: Market Analysis in the US by end user (2017-2025)
  • Figure 10: Automated Compounding Devices: Germany Market Analysis (2017-2025)
  • Figure 11: Automated Compounding Devices: Market Analysis in Germany by type (2017-2025)
  • Figure 12: Automated Compounding Devices: Market Analysis in Germany by application (2017-2025)
  • Figure 13: Automated Compounding Devices: Market Analysis in Germany by end user (2017-2025)
  • Figure 14: Automated Compounding Devices: France Market Analysis (2017-2025)
  • Figure 15: Automated Compounding Devices: Market Analysis in France by type (2017-2025)
  • Figure 16: Automated Compounding Devices: Market Analysis in France by application (2017-2025)
  • Figure 17: Automated Compounding Devices: Market Analysis in France by end user (2017-2025)
  • Figure 18: Automated Compounding Devices: Italy Market Analysis (2017-2025)
  • Figure 19: Automated Compounding Devices: Market Analysis in Italy by type (2017-2025)
  • Figure 20: Automated Compounding Devices: Market Analysis in Italy by application (2017-2025)
  • Figure 21: Automated Compounding Devices: Market Analysis in Italy by end user (2017-2025)
  • Figure 22: Automated Compounding Devices: Spain Market Analysis (2017-2025)
  • Figure 23: Automated Compounding Devices: Market Analysis in Spain by type (2017-2025)
  • Figure 24: Automated Compounding Devices: Market Analysis in Spain by application (2017-2025)
  • Figure 25: Automated Compounding Devices: Market Analysis in Spain by end user (2017-2025)
  • Figure 26: Automated Compounding Devices: United Kingdom Market Analysis (2017-2025)
  • Figure 27: Automated Compounding Devices: Market Analysis in the UK by type (2017-2025)
  • Figure 28: Automated Compounding Devices: Market Analysis in the UK by application (2017-2025)
  • Figure 29: Automated Compounding Devices: Market Analysis in the UK by end user (2017-2025)
  • Figure 30: Automated Compounding Devices: Japan Market Analysis (2017-2025)
  • Figure 31: Automated Compounding Devices: Market Analysis in Japan by type (2017-2025)
  • Figure 32: Automated Compounding Devices: Market Analysis in Japan by application (2017-2025)
  • Figure 33: Automated Compounding Devices: Market Analysis in Japan by end user (2017-2025)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers

The list of figures is not exhaustive; will be provided in the final report

Back to Top